Article citationsMore >>

Hamilton, A.J., Gutowski, N.J. “Aseptic meningitis in a patient receiving treatment with anti-tumour necrosis factor alpha.” J Neurol, 258: 1174-5. Dec.2011.

has been cited by the following article:

Article

Adalimumab Induced Aseptic Meningitis and Focal Partial Seizures in Patient with Crohn’s Disease

1Graduate Medical Education, UnityPoint Health-Des Moines, Des Moines, United States

2UnityPoint Clinic Multi-Specialty-Infectious Disease, UnityPoint Health, Des Moines, United States


American Journal of Medical Case Reports. 2019, Vol. 7 No. 11, 289-291
DOI: 10.12691/ajmcr-7-11-7
Copyright © 2019 Science and Education Publishing

Cite this paper:
Corey S. Ellis, Hayden L. Smith, Lisa A Veach. Adalimumab Induced Aseptic Meningitis and Focal Partial Seizures in Patient with Crohn’s Disease. American Journal of Medical Case Reports. 2019; 7(11):289-291. doi: 10.12691/ajmcr-7-11-7.

Correspondence to: Hayden  L. Smith, Graduate Medical Education, UnityPoint Health-Des Moines, Des Moines, United States. Email: hayden.smith@unitypoint.org

Abstract

Tumor necrosis factor α inhibitors (TNFα-i) are a commonly prescribed class of medications for the treatment of inflammatory bowel disease. With the increasing use of this medication class, some uncommon adverse effects have been reported. We present a case of a young male recently prescribed adalimumab for Crohn’s disease who developed aseptic meningitis with associated focal partial seizures.

Keywords